To enact sections 2305.2312, 3732.01, 3732.02, 3732.03, 3732.04, 3732.05, 3732.06, 3732.08, 3732.09, 3732.11, 3732.13, and 3732.14 of the Revised Code to protect assisted reproduction care.
HB237 would create a new set of protections for assisted reproduction care in Ohio, including fertility treatment, donor services, and related counseling, medications, and records. The bill defines “assisted reproduction care” broadly and bars civil liability, criminal prosecution, or professional discipline for health care providers, facilities, patients, donors, and helpers for providing, accessing, or supporting lawful assisted reproduction care, subject to exceptions for negligence, willful or wanton misconduct, and reckless disregard. It also states that loss or injury to human reproductive material is not to be treated as wrongful death, and it clarifies that reproductive material outside the uterus is not an unborn human individual, fetus, natural person, or similar personhood term.
The bill also creates a privacy framework for personal assisted reproduction or donor information. Regulated entities could collect, retain, use, or disclose such information only with express consent or when strictly necessary to provide a requested service. Individuals would have rights to access, delete, and obtain disclosures of their data, and regulated entities would have to maintain a detailed privacy policy. The bill authorizes private lawsuits, statutory damages, punitive damages, attorneys’ fees, and equitable relief for violations, and it also treats violations as unfair or deceptive acts under Ohio consumer protection law, enforceable by the attorney general.
In addition, HB237 limits state and local governments from prohibiting or unreasonably restricting access to assisted reproduction, ongoing treatment, use of reproductive material, provider services, or insurance coverage for such care, except for health and safety regulations that meet a narrow standard. It creates a cause of action against state or local governments for violating those protections and bars compelled disclosure of patient records to out-of-state third parties, including the federal government and law enforcement. The bill also requires informed consent and written disclosure of provider and facility policies before assisted reproduction care is performed.
The overall sentiment reflected by the bill’s introduction is supportive of assisted reproduction access and privacy, with the measure framed as a protection for patients, providers, and donors. Because there are no committee transcripts or recorded votes in the provided context, there is no documented opposition or debate in the available materials. The bill’s structure suggests its sponsors are aiming to insulate fertility care from legal uncertainty and government interference while strengthening data privacy and patient consent requirements.
Notable points of contention likely center on the bill’s broad privacy restrictions, its private right of action and damages provisions, and its explicit personhood language for reproductive material outside the uterus. The limits on state and local regulation, the prohibition on compelled disclosure to out-of-state entities, and the treatment of assisted reproduction information as sensitive data could raise concerns among opponents about enforcement, public records, law enforcement access, and the scope of state preemption.
HB237 would add new sections to the Revised Code governing civil liability, privacy, consumer protection, local government authority, records disclosure, and informed consent related to assisted reproduction. It would protect fertility patients, donors, providers, facilities, and support persons from liability for lawful assisted reproduction care, create new privacy and data-handling obligations for regulated entities, and authorize both private lawsuits and attorney general enforcement for violations. It would also restrict state and local governments from limiting access to assisted reproduction and would bar compelled disclosure of patient records to out-of-state third parties.
The bill appears generally favorable toward assisted reproduction access, privacy, and provider autonomy. In the materials provided, there are no committee transcripts or votes showing formal opposition or support beyond the bill’s introduction and referral to the House Health Committee. The framing of the bill and its sponsor list suggest a pro-access, pro-privacy policy approach.
Likely areas of contention include the bill’s broad immunity and liability provisions, the creation of a private right of action with statutory and punitive damages, and the strong restrictions on disclosure of assisted reproduction information. The explicit declaration that reproductive material outside the uterus is not a personhood-bearing entity may be controversial for opponents who favor broader fetal or embryo protections. Limits on state and local authority, including the prohibition on compelled disclosure to out-of-state entities and the protection of insurance coverage, may also draw criticism from those concerned about regulatory flexibility, law enforcement access, or conflicts with other state laws.